Zach CochranZachCochran

Convertible noteholders in a private negotiated exchange of outstanding convertible notes for new convertible notes and warrants issued by Electra Battery Material.

Evolent Health in multiple private exchanges of its outstanding convertible notes, the issuance of its Series A convertible preferred stock to finance (in part) its acquisition of Magellan Specialty Health and a $402.5 million convertible notes offering.

Convertible noteholders in a private negotiated exchange of outstanding convertible notes for first lien term loans and warrants issued by Veritone.

Investors in structuring and negotiating convertible note investments in Nogin and Compusecure to finance (in part) the IPO of each issuer through de-SPAC transactions.

Investors in structuring and negotiating first lien convertible note investments in Reed’s.

Various institutional investors in structuring and negotiating investments in convertible senior notes issued by, among others, Akoustis, LumiraDx, RumbleOn and NantHealth.

EVO Payments in its $250 million "Up-C" IPO, multiple secondary offerings and a $150 million convertible preferred stock investment by Madison Dearborn.

SunTrust Banks in various securities offerings, including public offerings of common stock, preferred stock and senior notes.

National Australia Bank and Great Western Bancorp in connection with Great Western Bancorp’s IPO.

Piedmont Office Realty Trust in multiple offerings of senior notes (including green senior notes) and in its at-the-market forward sale program.

Various issuers, including Nivalis Therapeutics, Endochoice and Americold Realty Trust, in connection with their IPOs.